Last updated: September 2, 2019
Sponsor: Imperial College London
Overall Status: Active - Recruiting
Phase
N/A
Condition
Glaucoma
Treatment
N/AClinical Study ID
NCT03758859
18SM4868
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients subjectively deemed to have poor image quality by the photographer
Exclusion
Exclusion Criteria:
Patients with a known adverse reaction to any of the constituents of the XLHA
Patients wearing contact lenses
Patients who have used eyedrops in the past 2 hours
Study Design
Total Participants: 80
Study Start date:
April 12, 2019
Estimated Completion Date:
October 31, 2019
Connect with a study center
Western Eye Hospital
London, NW1 5QH
United KingdomActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.